Top Markets
#1 DogBull DogBull +108.89%
#2 Siacoin Siacoin +62.61%
#3 MarsCoin MarsCoin +56.44%
#4 ADO Protocol ADO Protocol +52.97%
#5 The Bitcoin Bull The Bitcoin Bull +32.78%
#6 Ontology Gas Ontology Gas +19.78%
#7 Akedo Akedo +12.83%
#8 Arowana Arowana +11.61%
#9 UnifAI Network UnifAI Network +11.46%
#10 Cash Cat Cash Cat +11.11%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Stratec SE Stratec SE

Stratec SE

SBS
Rank in Stocks #15320
Established in 1979 and headquartered in Birkenfeld, Germany, Stratec SE... Established in 1979 and headquartered in Birkenfeld, Germany, Stratec SE (previously known as STRATEC Biomedical AG until its name change in December 2018) specializes in the development and manufacturing of cutting-edge automation and instrumentation systems. The company caters to the in-vitro diagnostics and life sciences sectors, operating across Germany, the European Union, and globally. Its business is divided into three primary segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment focuses on designing and fabricating automated analytical systems, along with necessary spare parts and supplies, for customers in clinical diagnostics and biotechnology. The Diatron segment provides a suite of systems, components, disposables, and assays for lower-volume hematology and clinical chemistry applications. Finally, the Smart Consumables segment is dedicated to engineering and producing intelligent consumables for the diagnostics, life sciences, and medical technology industries.
Share Price
$29.59
Market Cap
$359.75M
Change (1 day)
-1.58%
Change (1 year)
-4.28%
Country
DE
Trade Stratec SE (SBS)

Category

Healthcare
P/E ratio for Stratec SE (SBS)
P/E ratio as of 2026 TTM: 0
According to Stratec SE latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Stratec SE from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 35.48 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 33.28 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 19.48 -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 52.16 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.